DUBLIN–(BUSINESS WIRE)–The “Insulin Pens Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering.
The model discusses in detail the impact of COVID-19 on Insulin Pens Devices market for the year 2020 and beyond. Insulin pen is used to inject insulin for the treatment of diabetes. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose.
Insulin pens are classified into disposable and reusable insulin pens. Disposable insulin pens usually consist of pre-filled insulin cartridge which is disposed once the vial is over. In case of reusable insulin pens, the cartridge can be replaced once it is over.
Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Reasons to Buy
- Understand the impact of COVID-19 on Insulin Pens market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving Insulin Pens market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Insulin Pens market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Insulin Pens market from 2015-2030.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Key Inclusions of the market model are:
- Currently marketed Insulin Pens Devices and evolving competitive landscape
- Insightful review of the key industry trends.
- Annualized total Insulin Pens Devices market revenue by segment and market outlooks from 2015-2030.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights:
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition the analysts’ provide unique country specific insights on the market.
- SWOT analysis for Insulin Pens Devices market.
- Competitive dynamics insights and trends provided for Insulin Pens Devices market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Companies Mentioned
- Novo Nordisk AS
- Eli Lilly and Co
- Sanofi
For more information about this report visit https://www.researchandmarkets.com/r/b4zq8i
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
